CenExel CBH is seeking volunteers (ages 13-17) to participate in a child/teen clinical study on schizophrenia and/or psychosis. Schizophrenia is a disorder characterized by distorted perceptions of reality, including hallucinations, delusions and “disorganized” thinking and speech. These thoughts and feelings can be genetic, therefore if adult family members have a history of Schizophrenia and/or psychosis you should look out for the below symptoms on young adults and teenagers:
• hallucinations (hearing voices, or seeing or feeling things that are not there)
• delusions (beliefs that are not supported by reality)
• trouble thinking, such as feeling confused or “hazy”
• difficulty communicating clearly (other people are confused by what your child is saying).
Benefits for Children:
Access
Your child will have access to new medicines that aren’t available to the public yet which researchers believe will work better or are safer than the standard.
Closer Monitoring/Additional Testing
Clinical trials also offer closer monitoring or additional testing for your child compared to regular care.
Helping Future Generations
By testing the safety and effectiveness of new medicines, your child is helping future generations find what works and what doesn’t. Participating in a clinical trial will help researchers and the public learn more about how to treat your child’s condition while becoming part of a community that understands what you’re going through.
The Process:
All study medication, assessments, and procedures related to the study will be provided at no cost to you.
Before you and your child decide whether to take part, we will provide you with all the information you need, and you both will have a chance to ask questions. You and your child will be given plenty of time to decide about taking part in the study. This study will help us learn more about the investigational medication.
For more information, please call a member of the study team. By contacting us, your child is under no obligation to take part in the study.